机构：[1]Department of Pathology, School of Biology and Basic Medical Sciences, Soochow University, Suzhou 215123, China.[2]Department of Pathology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China.[3]Collaborative Innovation Center of Clinical Immunology Between Soochow University and Sihong People's Hospital, Sihong 223900, China.[4]Department of Pathology, Sihong People's Hospital, Sihong 223900, China.[5]Laboratory Animal Research Center, Soochow University School of Medicine, Suzhou 215123, China.[6]Department of Surgery, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.[7]Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.苏州大学附属第二医院[8]Suzhou Key Laboratory of Tumor Microenvironment and Pathology, Soochow University, Suzhou 215006, China.
We are retracting this article due to certain errors in two figures in the article “TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1
to inhibit prostate cancer progression” which has been published. An
image layout error occurred while processing Figure 3e, and some of
the images in Figure 3f, 4d, and 4e have errors due to incorrect image
grouping. We carried out a detailed investigation and rechecked the
original data of these figures. Unfortunately, the original pathological
data have not been properly archived; thus, we are unable to investigate this issue.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2021]版：
大类|2 区医学
小类|2 区男科学3 区泌尿学与肾脏学
最新[2025]版：
大类|2 区医学
小类|2 区男科学2 区泌尿学与肾脏学
第一作者：
第一作者机构：[1]Department of Pathology, School of Biology and Basic Medical Sciences, Soochow University, Suzhou 215123, China.[2]Department of Pathology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China.[3]Collaborative Innovation Center of Clinical Immunology Between Soochow University and Sihong People's Hospital, Sihong 223900, China.
共同第一作者：
通讯作者：
通讯机构：[1]Department of Pathology, School of Biology and Basic Medical Sciences, Soochow University, Suzhou 215123, China.[8]Suzhou Key Laboratory of Tumor Microenvironment and Pathology, Soochow University, Suzhou 215006, China.
推荐引用方式(GB/T 7714)：
Hu Yue-Mei,Lou Xiao-Li,Liu Bao-Zhu,et al.Retraction note: TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression[J].Asian Journal Of Andrology.2022,doi:10.4103/aja202285.
APA：
Hu Yue-Mei,Lou Xiao-Li,Liu Bao-Zhu,Sun Li,Wan Shan...&Wang Shou-Li.(2022).Retraction note: TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression.Asian Journal Of Andrology,,
MLA：
Hu Yue-Mei,et al."Retraction note: TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression".Asian Journal Of Andrology .(2022)
